Epstein Nancy E
Department of Neurosurgery, School of Medicine, State University of New York at Stony Brook, N,Y., U.S.A.
Surg Neurol Int. 2021 May 3;12:208. doi: 10.25259/SNI_317_2021. eCollection 2021.
Intraoperative traumatic cerebrospinal fluid (CSF) fistulas/dural tears (DT) occur in up to 8.7-9.5% of primary lumbar surgical procedures. Further, they recur secondarily in between 8.1% and 17% of cases. It is critical to diagnose and treat these recurrent lumbar DT early (i.e. within 3-4 weeks of the index surgery) to avoid the evolution of adhesive arachnoiditis (AA), and its' permanent neurological sequelae.
Postoperative lumbar CSF fistulas/DT should be diagnosed on postoperative MR scans, and confirmed on Myelo-CT studies if needed. They should be definitively treated/occluded early on (e.g. within 3-4 postoperative weeks) to avoid the evolution of AA which can be readily diagnosed on MR studies, and corroborated, if warranted, on Myelo-CT examinations. The most prominent MR/Myelo-CT findings include; nerve roots aggregated in the central thecal sac, nerve roots peripherally scarred/adherent to the surrrounding meningeal wall ("empty thecal sac sign"), soft tissue masses in the subarachnoid space, and/or multiple loculated/scarred compartments.
Percutaneous interventional procedures (i.e. epidural blood patches, injection of fibrin glue (FG)/fibrin sealants (FS)) are rarely effective for treating postoperative recurrent lumbar CSF fistulas. Rather, direct surgical occlusion is frequently warranted including the use of; an operating microscope, adequate surgical exposure, 7-0 Gore-Tex sutures, muscle/dural patch grafts or suture anchors, followed by the application of microfibrillar collagen, and fibrin sealant/glue.
Lumbar AA most commonly results from the early failure to diagnose and treat recurrent postoperative CSF fistulas. Since the clinical course of lumbar AA is typically one of progressive neurological deterioration, avoiding its' initial onset is key.
在原发性腰椎手术中,术中创伤性脑脊液(CSF)瘘/硬脑膜撕裂(DT)的发生率高达8.7% - 9.5%。此外,在8.1%至17%的病例中会继发复发。早期(即初次手术后3 - 4周内)诊断和治疗这些复发性腰椎DT至关重要,以避免粘连性蛛网膜炎(AA)的进展及其永久性神经后遗症。
术后腰椎CSF瘘/DT应通过术后磁共振成像(MR)扫描进行诊断,必要时通过脊髓CT研究进行确认。应尽早(例如术后3 - 4周内)进行明确治疗/封堵,以避免AA的进展,AA可通过MR研究轻松诊断,必要时通过脊髓CT检查得到证实。最显著的MR/脊髓CT表现包括:神经根聚集在中央硬膜囊内、神经根周围瘢痕形成/粘连于周围脑膜壁(“空硬膜囊征”)、蛛网膜下腔内软组织肿块和/或多个分隔/瘢痕形成的腔隙。
经皮介入治疗(即硬膜外血贴、注射纤维蛋白胶(FG)/纤维蛋白封闭剂(FS))对治疗术后复发性腰椎CSF瘘很少有效。相反,通常需要直接手术封堵,包括使用手术显微镜、充分的手术暴露、7-0 Gore-Tex缝线、肌肉/硬膜补片移植或缝线锚钉,随后应用微纤维胶原蛋白和纤维蛋白封闭剂/胶。
腰椎AA最常见的原因是早期未能诊断和治疗术后复发性CSF瘘。由于腰椎AA的临床病程通常是进行性神经功能恶化,避免其初始发作是关键。